Description
A selective progesterone receptor modulator (SPRM) that binds to human PR-A, PR-B, rabbit uterine PR, and rabbit thymic GR (EC50s = 8.5, 7.7, 13.6, and 15.4 nM, respectively); inhibits growth of IGROV-1 and SKOV3 human ovarian cancer cells (IC50s = 15.5 and 31.5 μM, respectively) even after resistance to combined cisplatin and paclitaxel treatment has developed; reverses the proliferative effect of progesterone on patient-derived germ-line mutant BRCA1 breast tissue xenografts in ovariectomized athymic mice; inhibits ovulation in female mice when administered within 6 h of treatment with hCG (40 mg/kg, i.p.)
Formal name: 17-(acetyloxy)-11β-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
Synonyms: CDB 2914|HRP 2000|RU 44675
Molecular weight: 475.6
CAS: 126784-99-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology||Research Area|Cancer|Multidrug Resistance||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Estrogens & Progestins||Research Area|Endocrinology & Metabolism|Reproductive Biology